JP5716018B2 - ラクリチンの部分ペプチド - Google Patents

ラクリチンの部分ペプチド Download PDF

Info

Publication number
JP5716018B2
JP5716018B2 JP2012513804A JP2012513804A JP5716018B2 JP 5716018 B2 JP5716018 B2 JP 5716018B2 JP 2012513804 A JP2012513804 A JP 2012513804A JP 2012513804 A JP2012513804 A JP 2012513804A JP 5716018 B2 JP5716018 B2 JP 5716018B2
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
catalog number
cells
lacritin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012513804A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504519A5 (https=
JP2013504519A (ja
Inventor
毅 中嶋
毅 中嶋
朋子 中嶋
朋子 中嶋
光佳 東
光佳 東
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Priority to JP2012513804A priority Critical patent/JP5716018B2/ja
Publication of JP2013504519A publication Critical patent/JP2013504519A/ja
Publication of JP2013504519A5 publication Critical patent/JP2013504519A5/ja
Application granted granted Critical
Publication of JP5716018B2 publication Critical patent/JP5716018B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2012513804A 2009-09-16 2010-09-16 ラクリチンの部分ペプチド Expired - Fee Related JP5716018B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012513804A JP5716018B2 (ja) 2009-09-16 2010-09-16 ラクリチンの部分ペプチド

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2009215030 2009-09-16
JP2009215030 2009-09-16
PCT/JP2010/066611 WO2011034207A1 (en) 2009-09-16 2010-09-16 Partial peptide of lacritin
JP2012513804A JP5716018B2 (ja) 2009-09-16 2010-09-16 ラクリチンの部分ペプチド

Publications (3)

Publication Number Publication Date
JP2013504519A JP2013504519A (ja) 2013-02-07
JP2013504519A5 JP2013504519A5 (https=) 2013-08-15
JP5716018B2 true JP5716018B2 (ja) 2015-05-13

Family

ID=43758803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012513804A Expired - Fee Related JP5716018B2 (ja) 2009-09-16 2010-09-16 ラクリチンの部分ペプチド

Country Status (4)

Country Link
US (1) US8518412B2 (https=)
EP (1) EP2478010B1 (https=)
JP (1) JP5716018B2 (https=)
WO (1) WO2011034207A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2681424T3 (es) * 2013-05-02 2018-09-13 Pharis Biotec Gmbh Protransducina B, un potenciador de la transferencia génica
JP6377618B2 (ja) * 2013-08-28 2018-08-22 千寿製薬株式会社 角膜上皮障害治療剤
WO2015138604A1 (en) * 2014-03-12 2015-09-17 University Of Virginia Patent Foundation Compositions and methods for treating eye infections and disease
BR112019017275A2 (pt) * 2017-02-21 2020-05-12 Tearsolutions, Inc. Composições peptídicas estáveis
CN112516080B (zh) * 2018-01-23 2023-09-19 盛元医药广州有限公司 一种眼用药物组合物及其制备方法和应用
KR102337935B1 (ko) * 2019-04-18 2021-12-10 코스맥스 주식회사 라크리틴을 포함하는 피부장벽 개선 및 보습 증진용 화장료 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806727A1 (fr) 2000-03-23 2001-09-28 Pf Medicament Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable
JP4288070B2 (ja) 2001-02-20 2009-07-01 ユニバーシティ オブ バージニア パテント ファウンデーション 眼涙増殖因子様タンパク質
JP5122278B2 (ja) 2004-05-13 2013-01-16 ユニバーシティ オブ バージニア パテント ファウンデーション 眼細胞生存の促進におけるラクリチンの使用
WO2008033477A2 (en) 2006-09-14 2008-03-20 University Of Virginia Patent Foundation Antimicrobial activity in variants of lacritin
EP2270141B9 (en) 2008-03-19 2015-12-16 Senju Pharmaceutical Co., Ltd. Partial peptide of lacritin

Also Published As

Publication number Publication date
US8518412B2 (en) 2013-08-27
EP2478010B1 (en) 2014-08-06
WO2011034207A1 (en) 2011-03-24
EP2478010A1 (en) 2012-07-25
JP2013504519A (ja) 2013-02-07
US20120245102A1 (en) 2012-09-27
EP2478010A4 (en) 2013-01-02

Similar Documents

Publication Publication Date Title
CN102655877B (zh) Fgf21突变体及其用途
US20120315256A1 (en) Use of transforming growth factor - beta 1 (tgf-b1) inhibitor peptides for the treatment of corneal fibrosis and/or haze
JP5716018B2 (ja) ラクリチンの部分ペプチド
JP5475640B2 (ja) ラクリチンの部分ペプチド
CA2133205C (en) Stable polypeptide composition
US9023795B2 (en) Angiogenesis-inhibiting peptide and application thereof
IL310154A (en) Recombinant variants of r-spondin proteins and their use
US20160060322A1 (en) Relaxin-like peptides and uses thereof
US20250243453A1 (en) Cell cultivation or proliferation substrate
TWI583698B (zh) 人類ｇｄｎｆ之變異體
CN102336812B (zh) 一种具有抑制血管生成活性的多肽
US10501511B2 (en) Low molecular polypeptide for preventing and treating inflammation and use thereof
CN102311485B (zh) 一种具有抑制新生血管作用的多肽及其应用
CN101503458B (zh) 预防和治疗血管新生的小分子多肽及其应用
CN103992376B (zh) 一种抑制新生血管的小肽及其应用
CN104004057B (zh) 一类抑制新生血管的小肽及其应用
CN111344300B (zh) Pacap的稳定化肽
CN103992377B (zh) 一种抑制新生血管的小肽及其应用
CN105017406A (zh) 一类新的具有神经保护功能的多肽

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130627

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130627

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141029

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150310

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150316

R150 Certificate of patent or registration of utility model

Ref document number: 5716018

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees